What protections exist for clinical trial participants?
An Institutional Review Board comprised of scientists and non-scientists of varied backgrounds, genders and ethnicities review all human subject research conducted at the Arizona Cancer Center to ensure that studies are ethical and participants are not likely to be harmed. The IRB can stop a study if it appears to be causing unexpected harm to participants or if it is clear that the new treatment is effective and should be made more widely available.
